Cancer

Eric Lefkofsky is a Chicago-based entrepreneur who has made quite the name for himself in the technological world. Known initially for co-founding Groupon, Lefkofsky is now working toward making a difference in the medical field with his next co-founding startup, Tempus. Tempus is a tech firm based out of Chicago that is working to incorporate …

Continue reading Eric Lefkofsky’s Addressing The Importance Of Cancer Care With New Company, Tempus.

Tempus Labs is a Chicago-based technology company founded in founded in the year 2015 by the city’s top entrepreneur and philanthropist, Eric Lefkofsky. The organization has built the world’s most extensive clinical and molecular data library with efficient operating system purposely to make that data useful and accessible to all the physicians treating cancer patients. …

Continue reading Eric Lefkofsky- Tempus Unicorn Funding

If you have been following the tech industry in recent years, then you’ve likely heard of the work that Eric Lefkofsky is doing with his newest company, Tempus. Lefkofsky co-founded Tempus back in 2015 with the goal of bringing creative solutions to the realm of cancer care by focusing on the role of Big Data …

Continue reading Eric Lefkofsky Looks To Big Data As Answer To Cancer Care.

Eric Lefkofsky. Eric Lefkofsky is the Chief Executive Officer and the Co-founder of Tempus. Tempus is a technological research company that uses an operating system to fight cancer. Eric is also a co-starter of Lightbank firm that deals in financial investment in troublesome technologies. Eric Lefkofsky is also one of the initiators of Groupon, and …

Continue reading Eric Lefkofsky.

The workers at The Cancer Treatment Centers of America love knowing that through their job they are able to make a difference in the world. Each worker puts as much passion as they possibly can into their work. They do this while also making sure that they are treating each patient like they are part …

Continue reading Cancer Treatments Of America Is Advancing In Their Treatments

Researchers at Oncotarget have found a potential treatment for the third most deadly type of cancer in the world, colon cancer. While traditional treatments generally include chemotherapy and bowel resection, Oncotarget has found that by combining methlglyoxal (MG), a glucose metabolite, and other functions of the glyoxalase system tumor growth was suppressed. Check the journal …

Continue reading Oncotarget’s Discovery May Lead to New Treatments for Colon Cancer

WebMD and Cancer Treatment Centers of America (CTCA) have a partnership in place that was designed to give the information to patients and their families they need in order to be better informed about the experience of having cancer. The partnership covers issues that come up during diagnosis of this disease and what treatment options …

Continue reading Why CTCA and WebMD Teamed Up To Provide Information About Cancer